$0.95
+0.03 (+2.92%)
Open$0.93
Previous Close$0.92
Day High$0.96
Day Low$0.92
52W High$3.28
52W Low$1.18
Volume—
Avg Volume441.3K
Market Cap543.02M
P/E Ratio—
EPS$-0.63
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+2,371.6% upside
Current
$0.95
$0.95
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 555.82M | 624.10M | 156.52M |
| Net Income | -513,445,929 | -518,865,187 | 22.40M |
| Profit Margin | -92.4% | -87.8% | 14.3% |
| EBITDA | -305,471,515 | -325,845,429 | 28.04M |
| Free Cash Flow | — | — | 15.05M |
| Rev Growth | -10.9% | -10.9% | +1.7% |
| Debt/Equity | 0.35 | 0.35 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |